Filing Details

Accession Number:
0001209191-18-025436
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-04-18 17:31:25
Reporting Period:
2018-04-16
Accepted Time:
2018-04-18 17:31:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1080709 Arena Pharmaceuticals Inc ARNA Pharmaceutical Preparations (2834) 232908305
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1170362 W Steven Spector C/O Arena Pharmaceuticals, Inc.
6154 Nancy Ridge Drive
San Diego CA 92121
Evp, General Counsel & Sec No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-04-16 15,001 $17.90 34,691 No 4 M Direct
Common Stock Acquisiton 2018-04-16 15,000 $18.10 49,691 No 4 M Direct
Common Stock Disposition 2018-04-16 20,901 $34.33 28,790 No 4 S Direct
Common Stock Disposition 2018-04-16 7,700 $35.00 21,090 No 4 S Direct
Common Stock Disposition 2018-04-16 1,400 $35.81 19,690 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2018-04-16 15,001 $0.00 15,001 $17.90
Common Stock Employee Stock Option (right to buy) Disposition 2018-04-16 15,000 $0.00 15,000 $18.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
14,999 2022-12-15 No 4 M Direct
34,530 2022-03-19 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person.
  2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.77 to $34.76, inclusive. The reporting person undertakes to provide Arena Pharmaceuticals, Inc., any security holder of Arena Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 3 and 4 to this Form 4.
  3. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.77 to $35.63, inclusive.
  4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.80 to $35.84, inclusive.
  5. The options vest in four equal annual installments and are exercisable once vested. The first and second installments became exercisable on December 15, 2016 and 2017, and the third and fourth installments vest on December 15, 2018 and 2019.
  6. The options vested in four equal annual installments on March 19, 2013, 2014, 2015 and 2016, and were immediately exercisable once vested.